Trademark: 97545066
Word
HABEPO
Status
Registered
Status Code
700
Status Date
Tuesday, June 18, 2024
Serial Number
97545066
Registration Number
7417122
Registration Date
Tuesday, June 18, 2024
Mark Type
4
Filing Date
Thursday, August 11, 2022
Published for Opposition
Tuesday, April 2, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Aug 15, 2022
New Application Entered
Aug 31, 2022
New Application Office Supplied Data Entered
May 30, 2023
Assigned To Examiner
Jun 1, 2023
Suspension Letter Written
Jun 1, 2023
Letter Of Suspension E-Mailed
Jun 1, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 12, 2023
Teas Change Of Owner Address Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Correspondence Received
Sep 29, 2023
Teas Response To Suspension Inquiry Received
Jan 10, 2024
Suspension Checked - To Attorney For Action
Feb 22, 2024
Approved For Pub - Principal Register
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Apr 2, 2024
Published For Opposition
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 18, 2024
Registered-Principal Register
Jun 18, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24